126 East Lincoln Avenue
Rahway, NJ 07065
United States
908 740 4000
https://www.merck.com
Setor(es): Healthcare
Indústria: Drug Manufacturers - General
Funcionários Integrais: 70.000
Nome | Título | Pagar | Exercido | Nascido em |
---|---|---|---|---|
Mr. Robert M. Davis J.D. | Chairman, President & CEO | 28,62M | 43,33M | 1967 |
Ms. Caroline Litchfield | Executive VP & CFO | 15,84M | N/A | 1969 |
Mr. Richard R. DeLuca Jr. | Executive VP & President of Merck Animal Health | 12,31M | 41,21M | 1963 |
Mr. Sanat Chattopadhyay | Executive VP & President of Merck Manufacturing Division | 12,78M | 64,11M | 1960 |
Dr. Dean Y. Li M.D., Ph.D. | Executive VP & President of Merck Research Laboratories | 18,55M | N/A | 1963 |
Mr. Dalton E. Smart III | Senior VP of Finance, Principal Accounting Officer & Global Controller | N/A | N/A | 1967 |
Mr. David Michael Williams | Executive VP and Chief Information & Digital Officer | N/A | N/A | 1969 |
Mr. Peter Dannenbaum | Vice President of Investor Relations | N/A | N/A | N/A |
Ms. Jennifer L. Zachary | Executive VP & General Counsel | 14,03M | 17,77M | 1978 |
Lisa LeCointe-Cephas | Senior VP and Chief Ethics & Compliance Officer | N/A | N/A | 1982 |
O QualityScore de governança da ISS da Merck & Co., Inc. a partir de 1 de abril de 2024 é 4. As principais pontuações para Auditoria são: 6; Conselho: 5; Direitos de Acionistas: 3; Compensação: 4.